Filing Details
- Accession Number:
- 0001209191-20-063764
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-16 16:02:39
- Reporting Period:
- 2020-12-15
- Accepted Time:
- 2020-12-16 16:02:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1422143 | Kura Oncology Inc. | KURA | Pharmaceutical Preparations (2834) | 611547851 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1785406 | Kathleen Ford | C/O Kura Oncology, Inc. 12730 High Bluff Drive, Suite 400 San Diego CA 92130 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-12-15 | 6,250 | $19.43 | 6,250 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-12-15 | 6,250 | $40.60 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-12-15 | 3,125 | $19.43 | 3,125 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-12-15 | 3,125 | $40.60 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option to purchase common stock | Disposition | 2020-12-15 | 9,375 | $0.00 | 9,375 | $19.43 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 221,875 | 2029-08-08 | No | 4 | M | Direct |
Footnotes
- The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2020.
- This transaction was executed in multiple trades at prices ranging from $40.07 to $41.57. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $40.06 to $41.315. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This option vests in 48 equal monthly installments commencing on August 9, 2019.
Billionaire Hedge Funds
